Trademark: 79148822
Status Date
Friday, December 17, 2021
Registration Number
4745656
Registration Date
Tuesday, June 2, 2015
Filing Date
Wednesday, April 16, 2014
Published for Opposition
Tuesday, March 17, 2015
Cancellation Date
Friday, December 17, 2021
41 Education and training services, namely, workshops and seminars in the field of branding, product valuation and pricing, healthcare, and economics; education and training services, namely, workshops and seminars in the field of design and facilitation of product value and strategy; workshops and seminars in the field of design and facilitation of product value; workshops and seminars in the field of economic strategies and support of health economic deliverables; workshops and seminars in the nature of training to instruct on planning, preparation, coordination and conducting of expert panels and advisory boards for presentations and briefing documents in the health care industry; training services in the field of facilitation of workshops with cross-functional teams and affiliates to develop and refine economic strategies and support the adaptation of health economic deliverables; and workshops and seminars in the field of cross-functional and regional applied health economics training
9 Software, namely, software for providing information on pricing and reimbursement assessments in health economic and market access strategies and plans in the health care industry
35 Advertising; commercial business management, and marketing and professional business consultancy; advertising products of third parties in the health care industry; business management, namely, marketing and professional consultation in pricing and reimbursement strategies for brands and products at all stages of lifecycle development; brand management for businesses; brand management for pharmaceutical and medical device companies; business management and consultation providing commercial and clinical commercial strategies and commercial strategies for the production of integrated evidence plans to support pricing, reimbursement and market access; commercial business management, namely, development of value strategies for internal communication with cross-functional teams and senior management of companies to facilitate internal decision making; commercial business management, namely, development of early pricing and reimbursement strategies for brands, product management consulting at all development stages, and licensing opportunities; commercial business management, namely, conducting of pricing and reimbursement landscape assessments; commercial business management, namely, conducting of competitor analyses and development of pathways for disease management for comparative effectiveness research planning; commercial business management, namely, development of payer objection handler documents identifying potential payer objections to product reimbursement and arguments to address them; preparation of briefing documents for payer advisory boards; commercial business management, namely, conducting qualitative small scale payer research for hypothesis generation and unbranded or branded payer message testing and validation; commercial business management, namely, providing placement for market access managers and directors; commercial business management, namely, development of health economics and outcomes research strategies to support internal communication with cross-functional teams and senior management to facilitate internal strategic decisions; commercial business management, namely, providing strategic support for the development of economic models; design and development of budget impact models; commercial business management, namely, development of actionable plans to support the value communication of a product; commercial business management, namely, planning, preparation, coordination and conducting of expert panels and advisory boards; planning and conducting of database-registry analyses
42 Scientific and technological services and research and design services relating thereto, namely, scientific and technological competitor analysis and developing pathways for disease management for competitive research planning, conducting qualitative payer research for hypothesis, testing and validation; design and development of computers and software; design and development of computers and software for third parties
Oct 24, 2022
Total Invalidation Processed By The Ib
Sep 25, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 23, 2022
Invalidation Processed
Aug 17, 2022
Total Invalidation Of Reg Ext Protection Created
Dec 17, 2021
Cancelled Section 71
Jun 2, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 26, 2018
New Representative At Ib Received
Oct 30, 2015
Final Decision Transaction Processed By Ib
Sep 25, 2015
Final Disposition Notice Sent To Ib
Sep 25, 2015
Final Disposition Processed
Sep 2, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jun 2, 2015
Registered-Principal Register
Mar 17, 2015
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2015
Published For Opposition
Mar 13, 2015
Notification Processed By Ib
Feb 25, 2015
Notification Of Possible Opposition Sent To Ib
Feb 25, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 25, 2015
Notification Of Notice Of Publication E-Mailed
Feb 25, 2015
Assigned To Examiner
Feb 10, 2015
Law Office Publication Review Completed
Feb 9, 2015
Assigned To Lie
Jan 23, 2015
Approved For Pub - Principal Register
Jan 23, 2015
Examiner's Amendment Entered
Jan 23, 2015
Notification Of Examiners Amendment E-Mailed
Jan 23, 2015
Examiners Amendment E-Mailed
Jan 23, 2015
Examiners Amendment -Written
Oct 19, 2014
Notification Of Final Refusal Emailed
Oct 19, 2014
Final Refusal E-Mailed
Oct 19, 2014
Final Refusal Written
Sep 19, 2014
Teas/Email Correspondence Entered
Sep 19, 2014
Correspondence Received In Law Office
Sep 19, 2014
Teas Response To Office Action Received
Aug 16, 2014
Refusal Processed By Ib
Jul 30, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Jul 30, 2014
Refusal Processed By Mpu
Jul 30, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Jul 29, 2014
Non-Final Action Written
Jul 28, 2014
Assigned To Examiner
Jul 22, 2014
Application Filing Receipt Mailed
Jul 16, 2014
New Application Office Supplied Data Entered In Tram
Jul 11, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
